Keywords: amgen, initiates, gdnf, trial, parkinson, begin, first

Amgen Initiates GDNF Trial In Parkinson's

Article | 19 August 1996

Print This

Amgen is to begin the first human clinical trial with its novel neurotrophic factor, glial cell line-derived neurotrophic factor, for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in